A human inhibitor of tumor necrosis factor alpha (Q36354795)

13 August 2017

A human inhibitor of tumor necrosis factor alpha (English)

1 reference

13 August 2017

Seckinger P

1

1 reference

13 August 2017

Isaaz S

series ordinal

2

1 reference

13 August 2017

Dayer JM

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 April 1988

1 reference

Journal of Experimental Medicine

13 August 2017

1 reference

13 August 2017

167

1 reference

13 August 2017

4

1 reference

13 August 2017

1511-1516

1 reference

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

30 September 2017

Interleukin-1 inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

A urine inhibitor of interleukin 1 activity that blocks ligand binding.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

An endotoxin-induced serum factor that causes necrosis of tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188924

Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta

30 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2833558

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1084/JEM.167.4.1511

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

2833558

1 reference